American Psychiatric Affiliation D, Affiliation AP. Diagnostic and Statistical Guide of Psychological Problems: DSM-5 (American Psychiatric Affiliation, 2013).
World Well being Organisation W. World Motion Plan on the Public Well being Response to Dementia 2017–2025 52 (World Well being Group, 2017).
Duong, S., Patel, T. & Chang, F. Dementia: What pharmacists have to know. Can. Pharm. J. CPJ. 150(2), 118 (2017).
Mattap, S. M. et al. The financial burden of dementia in low- and middle-income nations (LMICs): A scientific assessment. BMJ Glob. Well being 7(4), 1–14 (2022).
OECD, Group WH. Well being at a Look: Asia/Pacific 2020.
DOSM. Present Inhabitants Estimates Malaysia Malaysia: Division of Statistics Malaysia; 2023. up to date 12 April 2023. https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=155&bul_id=ZjJOSnpJR21sQWVUcUp6ODRudm5JZz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09.
Nor, N. & Ghazali, S. Malaysia in the direction of an ageing nation. GEOGRAFIA Malays. J. Soc. Area. 17(3), 234–245 (2021).
Prince, M. J., Wimo, A., Guerchet, M. M., Ali, G. C., Wu, Y.-T., Prina, M. World Alzheimer Report 2015-The World Impression of Dementia: An Evaluation of Prevalence, Incidence, Value and Developments (2015).
Schaller, S., Mauskopf, J., Kriza, C., Wahlster, P. & Kolominsky-Rabas, P. L. The primary price drivers in dementia: A scientific assessment. Int. J. Geriatr. Psychiatry. 30(2), 111–129 (2015).
Rees, G. C. A., Lee, S. Dementia in Asia Pasific Area (2006).
Abdin, E. et al. The societal price of dementia in Singapore: Outcomes from the WiSE research. J. Alzheimer’s Dis. 51(2), 439–449 (2016).
Kongpakwattana, Ok. et al. An actual-world proof evaluation of associations amongst prices, high quality of life, and disease-severity indicators of Alzheimer’s illness in Thailand. Worth Well being. 22(10), 1137–1145 (2019).
Dominguez, J. et al. Dementia incidence, burden and price of care: A Filipino community-based research. Entrance. Public Well being. 9, 628700 (2021).
Nakanishi, M. et al. Prices and useful resource use of community-dwelling sufferers with Alzheimer’s illness in Japan: 18-month outcomes from the GERAS-J research. Curr. Med. Res. Opin. 37(8), 1331–1339 (2021).
Fillit, H. & Hill, J. The prices of vascular dementia: A comparability with Alzheimer’s illness. J. Neurol. Sci. 203, 35–39 (2002).
Rojas, G. et al. Medical and financial traits related to direct prices of Alzheimer’s, frontotemporal and vascular dementia in Argentina. Int. Psychogeriatr. 23(4), 554–561 (2011).
Stephan, B. C. et al. Prediction of dementia threat in low-income and middle-income nations (the ten/66 Research): An unbiased exterior validation of present fashions. Lancet Glob. Well being. 8(4), e524–e535 (2020).
Koris, R. Financial Burden of Dementia and Healthcare Prices of Demented Aged in Malaysia (Universiti Putra Malaysia; 2018).
Nur, A. M., Aljunid, S. M., Ismail, N., Haron, S. A., Shafie, A. A., Nor, N. M., et al. Supplier prices of treating dementia among the many aged in authorities hospitals of Malaysia. Malays. J. Public Well being Med. 121–127 (2017).
Koris, R. et al. The price of healthcare amongst Malaysian community-dwelling aged. J. Ekonomi Malaysia. 53(1), 89–103 (2019).
Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., et al. Honest allocation of scarce medical sources within the time of Covid-19. Mass Med. Soc. 2049–2055 (2020).
Yunus, S. Z. S. A., Puteh, S. E. W., Ali, A. M. & Daud, F. The Covid impression to public healthcare utilization amongst city low-income sponsored neighborhood in Klang Valley Malaysia. Well being Serv. Res. Manag. Epidemiol. 8, 23333928211002410 (2021).
Ganapathy, S. S. et al. Prevalence of dementia and high quality of lifetime of caregivers of individuals dwelling with dementia in Malaysia. Geriatr. Gerontol. Int. 20(Suppl 2), 16–20 (2020).
Naing, L., Nordin, R. B., Abdul Rahman, H. & Naing, Y. T. Pattern measurement calculation for prevalence research utilizing Scalex and ScalaR calculators. BMC Med. Res. Methodol. 22(1), 209 (2022).
Jo, C. Value-of-illness research: Ideas, scopes, and strategies. Clin. Mol. Hepatol. 20(4), 327–337 (2014).
Tan, S. S. Microcosting in Financial Evaluations: Problems with Accuracy, Feasibility, Consistency and Generalisability (2009).
Spacirova, Z. et al. A basic framework for classifying costing strategies for financial analysis of well being care. Eur. J. Well being Econ. 21(4), 529–542 (2020).
MOH. Charges (Medical), (Value of Providers) Order 2014 (ed. Chamber, M. A. G.). (Ministry of Well being Malaysia, 2014).
Affiliation, G. A. O. T. W. M. World Medical Affiliation Declaration of Helsinki: Moral rules for medical analysis involving human topics. J. Am. Coll. Dent. 81(3), 14–18 (2014).
Chapko, M. Ok. et al. Equivalence of two healthcare costing strategies: Backside-up and top-down. Well being Econ. 18(10), 1188–1201 (2009).
Gustavsson, A. et al. Predictors of prices of care in Alzheimer’s illness: A multinational pattern of 1222 sufferers. Alzheimer’s Dement. 7(3), 318–327 (2011).
Mesterton, J. et al. Cross sectional observational research on the societal prices of Alzheimers illness. Curr. Alzheimer Res. 7(4), 358–367 (2010).
Wang, G. et al. Financial impression of dementia in growing nations: An analysis of Alzheimer-type dementia in Shanghai, China. J. Alzheimer’s Dis. 15(1), 109–115 (2008).
Olazarán, J. et al. Prices and high quality of life in community-dwelling sufferers with Alzheimer’s illness in Spain: Outcomes from the GERAS II observational research. Int. Psychogeriatr. 29(12), 2081–2093 (2017).
Rapp, T. et al. Useful resource use and price of Alzheimer’s illness in France: 18-month outcomes from the GERAS observational research. Worth Well being. 21(3), 295–303 (2018).
Wimo, A. et al. The GERAS research: A potential observational research of prices and useful resource use in neighborhood dwellers with Alzheimer’s illness in three European nations—Research design and baseline findings. J. Alzheimer’s Dis. 36(2), 385–399 (2013).
Jetsonen, V. et al. Complete price of care will increase considerably from early to gentle Alzheimer’s illness: 5-year ALSOVA follow-up. Age Ageing. 50(6), 2116–2122 (2021).
Yu, E. et al. The financial burden of Alzheimer’s illness in Zhejiang Province. J. Alzheimers Dis. 80(2), 539–553 (2021).
Lenox-Smith, A., Reed, C., Lebrec, J., Belger, M. & Jones, R. W. Useful resource utilisation, prices and medical outcomes in non-institutionalised sufferers with Alzheimer’s illness: 18-month UK outcomes from the GERAS observational research. BMC Geriatr. 16(1), 1–10 (2016).
Bruno, G., Mancini, M., Bruti, G., Dell’Agnello, G. & Reed, C. Prices and useful resource use related to Alzheimer’s illness in Italy: Outcomes from an observational research. J. Prev. Alzheimer’s Dis. 5(1), 1–10 (2018).
Hager, Ok., Henneges, C., Schneider, E., Lieb, M. & Kraemer, S. Alzheimer dementia: course and burden on caregivers: Information over 18 months from German individuals of the GERAS research. Der Nervenarzt. 89, 431–442 (2018).
Jia, J. et al. The price of Alzheimer’s illness in China and re-estimation of prices worldwide. Alzheimer’s Dement. 14(4), 483–491 (2018).
Tekin, S., Fairbanks, L. A., O’Connor, S., Rosenberg, S. & Cummings, J. L. Actions of every day dwelling in Alzheimer’s illness: Neuropsychiatric, cognitive, and medical sickness influences. Am. J. Geriatr. Psychiatry. 9(1), 81–86 (2001).
Alkhawaldeh, A. et al. Utility and use of Andersen’s behavioral mannequin as theoretical framework: A scientific literature assessment from 2012–2021. Iran. J. Public Well being. 52(7), 1346 (2023).
Beam, C. R. et al. Variations between ladies and men in incidence charges of dementia and Alzheimer’s illness. J. Alzheimer’s Dis. 64(4), 1077–1083 (2018).
Vina, J. & Lloret, A. Why ladies have extra Alzheimer’s illness than males: Gender and mitochondrial toxicity of amyloid-β peptide. J. Alzheimer’s Dis. 20(s2), S527–S533 (2010).
Fratiglioni, L. et al. Incidence of dementia and main subtypes in Europe: A collaborative research of population-based cohorts Neurologic Illnesses within the Aged Analysis Group. Neurology. 54(11 Suppl 5), S10–S15 (2000).
Allegri, R. F. et al. Financial impression of dementia in growing nations: An analysis of prices of Alzheimer-type dementia in Argentina. Int. Psychogeriatr. 19(4), 705–718 (2007).
Deb, A., Sambamoorthi, U., Thornton, J. D., Schreurs, B. & Innes, Ok. Direct medical expenditures related to Alzheimer’s and associated dementias (ADRD) in a nationally consultant pattern of older adults—An extra price method. Getting old Ment. Well being. 22(5), 619–624. https://doi.org/10.1080/1360786320171286454 (2017).
Tonelli, M. et al. Age, multimorbidity and dementia with well being care prices in older individuals in Alberta: A population-based retrospective cohort research. Can. Med. Assoc. Open Entry J. 10(3), E577–E588 (2022).
Gustavsson, A. et al. Variations in useful resource use and prices of dementia care between European nations: Baseline knowledge from the ICTUS research. J. Nutr. Well being Getting old. 14, 648–654 (2010).
Denton, F. T. & Spencer, B. G. Continual well being situations: Altering prevalence in an ageing inhabitants and a few implications for the supply of well being care providers. Can. J. Getting old La Revue canadienne du vieillissement. 29(1), 11–21 (2010).
Broemeling, A.-M., Watson, D. E. & Prebtani, F. Inhabitants patterns of power well being situations, co-morbidity and healthcare use in Canada: Implications for coverage and follow. Healthc. Q. (Toronto, Ont). 11(3), 70–76 (2008).
Sharma, S. et al. Predictors of falls and fractures resulting in hospitalization in individuals with dementia: A consultant cohort research. J. Am. Med. Dir. Assoc. 19(7), 607–612 (2018).
Fischer, S. et al. Estimating the long-term purposeful burden of osteoporosis-related fractures. Osteoporos. Int. 28(10), 2843–2851 (2017).
Vun, J. S., Ahmadi, M., Panteli, M., Pountos, I. & Giannoudis, P. V. Dementia and fragility fractures: Points and options. Damage. 48, S10–S16 (2017).
Poblador-Plou, B. et al. Comorbidity of dementia: A cross-sectional research of main care older sufferers. BMC Psychiatry. 14(1), 1–8 (2014).
Bunn, F. et al. Comorbidity and dementia: A scoping assessment of the literature. BMC Med. 12(1), 1–15 (2014).
Silva, M. V. F. et al. Alzheimer’s illness: Threat elements and probably protecting measures. J. Biomed. Sci. 26, 1–11 (2019).
Yan, X., Li, F., Chen, S. & Jia, J. Related elements of whole prices of Alzheimer’s illness: A cluster-randomized observational research in China. J. Alzheimer’s Dis. 69(3), 795–806 (2019).
Malaysia DOS. Present inhabitants estimates, Malaysia, 2022. Inhabitants and Demography. (2022).
Cheah, Y. Ok. & Meltzer, D. Ethnic variations in participation in medical check-ups among the many aged: Proof from Malaysia. J. Gen. Intern. Med. 35, 2680–2686 (2020).
